Beckman’s year of uncertainty continues as it looks to strategic options
This article was originally published in Clinica
Executive Summary
It has not been a vintage year for biomedical test and lab systems manufacturer Beckman Coulter, and may even be the last one under its current ownership structure, if reports in mid-month are to be believed.